Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon‐like peptide 1 (GLP‐1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits
作者
K. Y. Thong,Robert E. J. Ryder,Melissa Cull,Chris Walton,on behalf of the ABCD nationwide exenatide and liraglutide audit contributors (for list of contributors, see Supporting Information, Appendix S2)
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
null
OK
invisight
乐空思
极限001
xing_xing
老迟到的涫
LYSM
Yinxb
花开富贵
稳重的翠曼
Mic
arniu2008
科研狗
DW
渡人舟
GingerF
忧心的曼凝
prigogin
皖公网安备34019202002308
